Comments

Valneva Stock Price, Quotes and Forecasts

Q: What sector and industry does Valneva (VALN) operate in?

Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VALNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.13

0.070.99%

Pre-Market: Mar 3, 6:17 AM EDT

Q4 2024 Earnings in 8 days from now on Thu Mar 20th, before the market open

Valneva (VALN) Forecast

News Earnings Valneva (VALN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Valneva Stock Price, Quotes and Forecasts | NASDAQ:VALN | Benzinga

Explore Valneva stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VALN.

Open	-
Close	-
Volume / Avg.	0 / 61.73K
Day Range	- - -
52 Wk Range	3.62 - 9.50
Market Cap	$578.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	0.05%
Days to Cover	1

Recent News

Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot

Valneva chikungunya vaccine shows strong, sustained immune response in adolescents, supporting potential approvals in Brazil and other regions.

Vandana Singh

Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Valneva's Chikungunya Shot Shows Strong, Long-Lasting Antibody Persistence At Three Years, Comparable In Older And Younger Adults

Valneva reports long-lasting antibody persistence in its chikungunya vaccine three years post-dose, supporting its global approvals and expansion efforts.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 61.73K
Day Range	- - -
52 Wk Range	3.62 - 9.50
Market Cap	$578.95M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	0.05%
Days to Cover	1

About Valneva SE

Sector

Health Care

Industry

Biotechnology

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes t...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Valneva (VALN) stock?

You can purchase shares of Valneva (NASDAQ:VALN) through any online brokerage.

View our list of the best stock brokerages

Who are Valneva (VALN) competitors?

Other companies in Valneva’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Precigen (NASDAQ:PGEN), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).

What is the forecast, or price target, for Valneva (VALN) stock?

Valneva has a consensus price target of $17.00.

What is the current price for Valneva (VALN)?

The stock price for Valneva (NASDAQ: VALN) is $7.13 last updated March 3, 2025 at 6:17 AM EST.

Does Valneva (VALN) pay a dividend?

There are no upcoming dividends for Valneva.

When is Valneva (NASDAQ:VALN) reporting earnings?

Valneva’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Valneva (VALN) going to split?

There is no upcoming split for Valneva.

What sector and industry does Valneva (VALN) operate in?

Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.